An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2–dominated inflammatory response
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
In schistosomiasis, chronic parasite egg-induced granuloma formation can lead to tissue destruction and fibrosis, which causes much of the morbidity and mortality associated with this disease. Here we show the importance of IL-13 in the pathogenesis of schistosomiasis, and demonstrate, perhaps for the first time, the therapeutic efficacy of an IL-13 inhibitor, sIL-13Ralpha2-Fc, in the control of hepatic fibrosis. T-helper type 2 (Th2) cytokines dominate the immune response in mice infected with Schistosoma mansoni, yet the specific contributions of IL-13 and IL-4 to the development of fibrosis were not previously investigated. Our studies demonstrate that both cytokines play redundant roles in granuloma formation, which explains the ability of IL-4-deficient mice to form granulomas around eggs. More importantly, however, these studies demonstrate that IL-13 is the dominant Th2-type cytokine regulating fibrosis. IL-13 stimulated collagen production in fibroblasts, and procollagen I and procollagen III mRNA expression was decreased in sIL-13Ralpha2-Fc-treated mice. Moreover, the reduction in fibrosis observed in IL-4-deficient mice was much less pronounced than that in sIL-13Ralpha2-Fc-treated animals. Fibrosis is a major pathological manifestation of a number of allergic, autoimmune, and infectious diseases. Thus, our findings provide evidence that IL-13 inhibitors may be of general therapeutic benefit in preventing damaging tissue fibrosis resulting from Th2-dominated inflammatory responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-11, a member of the IL-6/gp130 cytokine family, may be one such target as it was recently shown to integrate pro-fibrotic signals emanating from both pathways146–149”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [147]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617 · cited 2×
“IL-13 was also recently shown to play a central role in murine asthma (30, 31).”
BackgroundSelf-citationRequirement for IL-13 Independently of IL-4 in Experimental Asthma
Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,849
Self-citationZhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719 · cited 1×
“Indeed, the targeted pulmonary expression of IL-13 was shown to cause mucus cell metaplasia, airway fibrosis, and nonspecific airway hyperreactivity (43).”
BackgroundStat6 Is Required for Mediating Responses to IL-4 and for the Development of Th2 Cells
Kaplan, M. H., Schindler, U., Smiley, S. T., & Grusby, M. J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80439-2 · Cited by 1,628 · cited 1×
“In contrast to these observations, granuloma formation and the development of hepatic fibrosis was severely impaired in Stat6-deficient mice (10), which display a major defect in the production of several Th2-associated cytokines (39).”
ResultTwo Improved and Simplified Methods for the Spectrophotometric Determination of Hydroxyproline.
Bergman, I., & Loxley, R. (1963) · Analytical Chemistry · doi:10.1021/ac60205a053 · Cited by 1,525 · cited 1×
“Specifically, hepatic collagen was measured as hydroxyproline by the technique of Bergman and Loxley after hydrolysis of a 200-mg portion of liver in 5 mL of 6 N HCl at 110°C for 18 hours (35).”
MethodDisruption of the murine IL-4 gene blocks Th2 cytokine responses
Kopf, M., Gros, G. L., Bachmann, M., Lamers, M. C., Bluethmann, H., & Köhler, G. (1993) · Nature · doi:10.1038/362245a0 · Cited by 1,203 · cited 2×
“Whereas it is well known that IL-4 is the primary cytokine driving CD4+ Th2 cell development (15, 16), the role of IL-13 in the generation and maintenance of Th2-type responses remains controversial and may be influenced by both host genetics and the infectious disease model under study (24, 27, 29).”
BackgroundLe Gros, G., Ben-Sasson, S. Z., Seder, R., Finkelman, F. D., & Paul, W. E. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.3.921 · Cited by 954 · cited 2×
“Whereas it is well known that IL-4 is the primary cytokine driving CD4+ Th2 cell development (15, 16), the role of IL-13 in the generation and maintenance of Th2-type responses remains controversial and may be influenced by both host genetics and the infectious disease model under study (24, 27, 29).”
BackgroundPearce, E. J., Caspar, P., Grzych, J. M., Lewis, F. A., & Sher, A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.1.159 · Cited by 765
Urban, J. F., Noben-Trauth, N., Donaldson, D. D., Madden, K. B., Morris, S. C., Collins, M., & Finkelman, F. D. (1998) · Immunity · doi:10.1016/s1074-7613(00)80477-x · Cited by 580
Self-citationGrzych, J. M., Pearce, E., Cheever, A., Caulada, Z. A., Caspar, P., Heiny, S., Lewis, F., & Sher, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.4.1322 · Cited by 542
Self-citation
Cited by
Items 201–300 of 608
Straw, A. D., MacDonald, A. S., Denkers, E., & Pearce, E. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.2.727 · Cited by 95
Lundy, S. K., & Lukacs, N. W. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00039 · Cited by 95
“In contrast to IL-4, IL-13 is also involved in the induction of collagen synthesis by granuloma fibroblasts through binding to the specific IL-13R (Chiaramonte et al., 1999a; Fallon et al., 2000a).”
BackgroundEffects of Th2 Cytokines on Expression of Collagen, MMP-1, and TIMP-1 in Conjunctival Fibroblasts
Leonardi, A., Cortivo, R., Fregona, I. A., Plebani, M., Secchi, A., & Abatangelo, G. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0420 · Cited by 82
Osteopontin Deficiency Protects against Airway Remodeling and Hyperresponsiveness in Chronic Asthma
Simoes, D. C. M., Xanthou, G., Petrochilou, K., Panoutsakopoulou, V., Roussos, C., & Gratziou, C. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1081oc · Cited by 80
Type 2 Immune Mechanisms in Carbon Nanotube-Induced Lung Fibrosis
Dong, J., & Ma, Q. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01120 · Cited by 83
“IL-13-driven fibrosis is observed in cases of parasitic egg deposition, fungus and virus-associated pulmonary fibrosis, post-irradiation-induced fibrosis, and silicosis (11, 50, 51).”
Taylor, J. J., Krawczyk, C. M., Mohrs, M., & Pearce, E. J. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36534 · Cited by 82
Regulation of T helper type 2 cell immunity by interleukin-4 and interleukin-13
McKenzie, A. N. J. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00088-7 · Cited by 89
Antifibrotic Therapies in the Liver
Schuppan, D., & Mehal, W. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1550055 · Cited by 75
Emerging therapeutic targets for the treatment of hepatic fibrosis
Fagone, P., Mangano, K., Pesce, A., Portale, T. R., Puleo, S., & Nicoletti, F. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.10.015 · Cited by 77
Smith, K. A., Filbey, K. J., Reynolds, L. A., Hewitson, J. P., Harcus, Y., Boon, L., Sparwasser, T., Hämmerling, G., & Maizels, R. M. (2016) · Mucosal Immunology · doi:10.1038/mi.2015.73 · Cited by 76
Murray, H. W., Flanders, K. C., Donaldson, D. D., Sypek, J. P., Gotwals, P. J., Liu, J., & Ma, X. (2005) · Infection and Immunity · doi:10.1128/iai.73.7.3903-3911.2005 · Cited by 75
Self-citationA role for T lymphocytes in mediating cardiac diastolic function
Yu, Q., Watson, R. R., Marchalonis, J. J., & Larson, D. F. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00073.2005 · Cited by 74
“The lymphocyte has recently been shown to modulate fibroblast collagen formation in noncardiac tissues, namely, hepatic, dermal, pulmonary, and synovial tissues (8, 9, 21, 34).”
BackgroundLiu, T., Barrett, N. A., Kanaoka, Y., Yoshimoto, E., Garofalo, D., Cirka, H., Feng, C., & Boyce, J. A. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700603 · Cited by 75
Hepatic Granulomas: Pathogenesis and Differential Diagnosis
Lagana, S. M., Moreira, R. K., & Lefkowitch, J. H. (2010) · Clinics in Liver Disease · doi:10.1016/j.cld.2010.07.005 · Cited by 74
“The granulomatous response is usually of the TH2 variety, and it has recently been demonstrated that IL-13 blockade may aid in preventing fibrosis, which is responsible for much of the morbidity and mortality.(50)”
BackgroundSchistosomiasis‐Associated Pulmonary Hypertension
Papamatheakis, D. G., Mocumbi, A. O., Kim, N. H., & Mandel, J. (2014) · Pulmonary Circulation · doi:10.1086/678507 · Cited by 78
IL-11 Receptor α in the Pathogenesis of IL-13-Induced Inflammation and Remodeling
Chen, Q., Rabach, L., Noble, P., Zheng, T., Lee, C. G., Homer, R. J., & Elias, J. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2305 · Cited by 74
“The Th2 cytokine hypothesis suggests that fibrosis is the result of Th2-dominated tissue inflammation and that IL-13 is the major mediator of these fibrotic responses (1, 6 , 30, 50).”
BackgroundImmunostimulatory DNA Inhibits Transforming Growth Factor-β Expression and Airway Remodeling
Cho, J. Y., Miller, M., Baek, K. J., Han, J. W., Nayar, J., Rodriguez, M., Lee, S. Y., McElwain, K., McElwain, S., Raz, E., et al. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0066oc · Cited by 73
“In vivo studies in a parasite model of liver fibrosis demonstrate that an IL-13 inhibitor blocks the development of hepatic fibrosis during this Th2-dominated inflammatory response ( 27 ).”
BackgroundYang, Y., Wu, X.-Q., Li, W.-X., Huang, H.-M., Li, H.-D., Pan, X.-Y., Li, X.-F., Huang, C., Meng, X.-M., Zhang, L., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0383-0 · Cited by 72
Role of interleukin‐13 in fibrosis, particularly systemic sclerosis
O’Reilly, S. (2013) · BioFactors · doi:10.1002/biof.1117 · Cited by 71
NAFLD and HBV interplay - related mechanisms underlying liver disease progression
Tourkochristou, E., Assimakopoulos, S. F., Thomopoulos, K., Marangos, M., & Triantos, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.965548 · Cited by 70
Macrophage and Innate Lymphoid Cell Interplay in the Genesis of Fibrosis
Hams, E., Bermingham, R., & Fallon, P. G. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00597 · Cited by 75
“As reported first by Wynn and colleagues using soluble IL-13Ralpha2-Fc (86), a specific role for IL-13 in fibrosis was identified with anti-IL-13 antibodies now in clinical trials for fibrotic diseases (91).”
BackgroundIdiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs
Hadjicharalambous, M. R., & Lindsay, M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020524 · Cited by 75
“TH-2 effector T cells are thought to promote fibrosis via the production of pro-inflammatory cytokines such as interleukin 13 (IL-13) which stimulates collagen deposition in fibroblasts [55].”
BackgroundCytokine regulation of IL-13Rα2 and IL-13Rα1 in vivo and in vitro
Zheng, T., Zhu, Z., Liu, W. Y., Lee, C. G., Chen, Q., Homer, R., & Elias, J. A. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1383 · Cited by 70
IL-13/IL-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms
Melo‐Cardenas, J., Bezavada, L., Crawford, J. C., Gurbuxani, S. K., Cotton, A., Kang, G., Gossett, J. M., Marinaccio, C., Weinberg, R. S., Hoffman, R., et al. (2022) · Blood · doi:10.1182/blood.2022017326 · Cited by 74
Fairfax, K. C., Amiel, E., King, I. L., Freitas, T. C., Mohrs, M., & Pearce, E. J. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002490 · Cited by 69
“The Th2 response is essential for host survival [5,6,7] but also leads to hepatic fibrosis during chronic infection due primarily to the profibrotic effects of IL-13, a major cytokine product of Th2 cells [6,8,9].”
BackgroundThe inflammasome accelerates radiation-induced lung inflammation and fibrosis in mice
Sohn, S.-H., Lee, J. M., Park, S., Yoo, H., Kang, J. W., Shin, D., Jung, K., Lee, Y., Cho, J., & Bae, H. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.02.019 · Cited by 67
Kamal, S. M., Bianchi, L., Tawil, A. A., Koziel, M. J., Khalifa, K., Peter, T., & Rasenack, J. W. F. (2001) · The Journal of Infectious Diseases · doi:10.1086/323352 · Cited by 67
“The high fibrosis scores of patients with concomitant infection may be immunologically mediated with predominance or up-regulation of the collagen-inducing cytokine IL-4 and the down-regulation of the collagen-suppressing cytokine IFN-g, as was detected in our study and in other studies of schistosomiasis in mice [43,…”
ResultRutitzky, L. I., & Stadecker, M. J. (2011) · European Journal of Immunology · doi:10.1002/eji.201041327 · Cited by 64
Matsuda, M., & Seki, E. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111556 · Cited by 62
The IL-4Rα pathway in macrophages and its potential role in silica-induced pulmonary fibrosis
Migliaccio, C. T., Buford, M. C., Jessop, F., & Holian, A. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0807533 · Cited by 65
“, cytokine production and/or cellular response) present with increased inflammation but decreased or ablated fibrosis [10, 11, 35, 37].”
BackgroundImmunoregulation of Liver Fibrosis: New Opportunities for Antifibrotic Therapy
(2024) · doi:10.1146/annurev-pharmtox-020524-012013 · Cited by 64
Rolot, M., & Dewals, B. G. (2018) · Journal of Immunology Research · doi:10.1155/2018/2790627 · Cited by 74
“mansoniinduced liver fibrosis to a greater extent than suppression of IL-4 [90].”
BackgroundWu, B., Liu, J., Li, Y., & Li, J. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4395 · Cited by 73
“Previous studies had revealed that M2 macrophage-derived cytokines, including IL-4, IL-13 and IL‐10, regulate the chronic inflammatory response and ameliorate wound healing in the liver (16-19).”
ResultChandriani, S., DePianto, D. J., N’Diaye, E. N., Abbas, A. R., Jackman, J., Bevers, J., Ramirez-Carrozzi, V., Pappu, R., Kauder, S. E., Toy, K., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301761 · Cited by 63
“fibrosis whereas IL-13Ra1–deficient animals exhibit decreased tissue fibrosis (13, 26, 27).”
BackgroundWen, H., Hogaboam, C. M., Gauldie, J., & Kunkel, S. L. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051155 · Cited by 63
“IL-13 is a key mediator in the fibrotic process during schistosomiasis.(41) Conversely, mice receiving exogenous IL-12 protein develop smaller pulmonary and hepatic granulomas and exhibit less severe tissue fibrosis.”
BackgroundTh2 immune response against Schistosoma mansoni infection
Schramm, G., & Haas, H. (2010) · Microbes and Infection · doi:10.1016/j.micinf.2010.06.001 · Cited by 62
Kaminski, N., Belperio, J. A., Bitterman, P. B., Chen, L., Chensue, S. W., Choi, A. M. K., Đačić, S., Dauber, J. H., du Bois, R. M., Enghild, J. J., et al. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0159su · Cited by 63
The pathophysiology of chronic graft-versus-host disease: the unveiling of an enigma
Min, C. (2011) · The Korean Journal of Hematology · doi:10.5045/kjh.2011.46.2.80 · Cited by 61
“In a microarray analysis study, the expression of type 1 (IFN-γ) and type 2 (IL-6, IL-10, and IL-13) cytokines, chemokines, and a variety of growth factors and cell adhesion molecules were upregulated in recipients with CGVHD compared to recipients without it [77].”
BackgroundInfluentialFibroproliferative genes are preferentially expressed in central centrifugal cicatricial alopecia
Aguh, C., Dina, Y., Talbot, C. C., & Garza, L. A. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.05.1257 · Cited by 62
Is Interleukin-13 Critical in Maintaining Airway Hyperresposiveness in Allergen-challenged Mice?
Leigh, R., Ellis, R., Wattie, J., Donaldson, D. D., & Inman, M. D. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200311-1488oc · Cited by 62
“Data from preclinical studies suggest a potential impact of IL-13 antagonism on airway remodeling, with evidence that sIL-13R2.Fc treatment significantly blocks collagen formation in a model of hepatic fibrosis ( 46 ), and also prevents collagen deposition in chronic allergic airway inflammation (47).”
BackgroundSelf-citationMentink–Kane, M. M., Cheever, A. W., Wilson, M. S., Madala, S. K., Beers, L. M., Ramalingam, T. R., & Wynn, T. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.08.008 · Cited by 59
Self-citationTherapeutic pro-fibrogenic signaling pathways in fibroblasts
Cannito, S., Novo, E., & Parola, M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.017 · Cited by 62
“In particular, IL-13 has emerged as a major TH2 cytokine in mediating fibrosis as shown in different models, tissue and organs [1] including liver fibrosis of different etiology [52-54], IPF and experimental lung fibrosis [55,56].”
BackgroundBazzone, L. E., Smith, P. M., Rutitzky, L. I., Shainheit, M. G., Urban, J. F., Setiawan, T., Blum, A. M., Weinstock, J. V., & Stadecker, M. J. (2008) · Infection and Immunity · doi:10.1128/iai.00673-08 · Cited by 63
“On the other hand, an unopposed Th2 response signaled by the production of IL-4, IL-5, IL-10, and IL-13 results in a milder pathology (55), although there is a risk of increased hepatic fibrosis at a late stage of the disease, mainly through the action of IL-13 (15, 23).”
BackgroundComparison of transforming growth factor beta expression in healthy and diseased human tendon
Goodier, H., Carr, A. J., Snelling, S. J. B., Roche, L., Wheway, K., Watkins, B., & Dakin, S. G. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-0947-8 · Cited by 59
Interleukin 13: A Growth Factor in Hodgkin Lymphoma
Skinnider, B., Kapp, U., & Mak, T. W. (2001) · International Archives of Allergy and Immunology · doi:10.1159/000049523 · Cited by 64
T-bet deficiency attenuates cardiac remodelling in rats
Ma, Z., Dai, J., Yuan, Y., Bian, Z., Xu, S., Jin, Y., Zhang, X., & Tang, Q. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0678-x · Cited by 59
Akbar, M., Crowe, L. A. N., McLean, M., Melchor, E. G., MacDonald, L., Carter, K. A., Fazzi, U. G., Martin, D. P., Arthur, A., Reilly, J. H., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102715118 · Cited by 64
Role for hedgehog pathway in regulating growth and function of invariant NKT cells
Syn, W., Witek, R. P., Curbishley, S. M., Jung, Y., Choi, S. S., Enrich, B., Omenetti, A., Agboola, K. M., Fearing, C. M., Tilg, H., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200838890 · Cited by 58
Regulation of Helminth-Induced Th2 Responses by Thymic Stromal Lymphopoietin
Ramalingam, T. R., Pesce, J. T., Mentink-Kane, M. M., Madala, S., Cheever, A. W., Comeau, M. R., Ziegler, S. F., & Wynn, T. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900181 · Cited by 57
“The decrease in fibrosis was associated with increased IFN- -producing CD4 T cells in the liver and a small decrease in the production of IL-13, which was consistent with the respective anti- and profibrotic activities of IFN- and IL-13 (34, 45, 56).”
BackgroundResultSelf-citationIL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway
Kim, H. J., Song, S. B., Choi, J., Kim, K. M., Cho, B. K., Cho, D. H., & Park, H. J. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.302 · Cited by 63
Homer, R. J., Zheng, T., Chupp, G. L., He, S., Zhu, Z., Chen, Q., Ma, B., Hite, R. D., Gobran, L. I., Rooney, S. A., et al. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00438.2001 · Cited by 58
“A dominant role of IL-13 over IL-4 in promoting tissue fibrosis has previously been shown in hepatic schistosomiasis (6, 13).”
BackgroundPGD2-CRTH2 Pathway Promotes Tubulointerstitial Fibrosis
Ito, H., Yan, X., Nagata, N., Aritake, K., Katsumata, Y., Matsuhashi, T., Nakamura, M., Hirai, H., Urade, Y., Asano, K., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012020126 · Cited by 57
Interleukin-13 as an important cytokine: A review on its roles in some human diseases
Seyfizadeh, N., Seyfizadeh, N., Gharibi, T., & Babaloo, Z. (2015) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.62.2015.4.2 · Cited by 63
Enhanced protection from fibrosis and inflammation in the combined absence of IL‐13 and IFN‐γ
Ramalingam, T. R., Gieseck, R. L., Acciani, T. H., M Hart, K., Cheever, A. W., Mentink‐Kane, M. M., Vannella, K. M., & Wynn, T. A. (2016) · The Journal of Pathology · doi:10.1002/path.4733 · Cited by 55
“cytokine responses [39–42], with IFN-γ suppressing myofibroblast function and IL-4 and IL-13 augmenting their activity [16,43].”
BackgroundSelf-citationImmunological Regulation of Intestinal Fibrosis in Inflammatory Bowel Disease
Bamias, G., Pizarro, T. T., & Cominelli, F. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab251 · Cited by 60
IL-13 Fusion Cytotoxin Ameliorates Chronic Fungal-Induced Allergic Airway Disease in Mice
Blease, K., Jakubzick, C., Schuh, J. M., Joshi, B. H., Puri, R. K., & Hogaboam, C. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6583 · Cited by 57
“Consistent with these findings is the demonstration that the exogenous delivery of soluble (s)IL-13R 2-Fc effectively reduced the hepatic fibrosis associated with schistosomiasis (39).”
Bertoletti, A., & Ferrari, C. I. (2013) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2011-301073rep · Cited by 61
Saux, C. J. L., Teeters, K., Miyasato, S. K., Hoffmann, P. R., Bollt, O., Douet, V., Shohet, R. V., Broide, D. H., & Tam, E. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701572200 · Cited by 60
Wu, D. X.-Y., Ahrens, R., Osterfeld, H., Noah, T. K., Groschwitz, K. R., Foster, P. S., Steinbrecher, K. A., Rothenberg, M. E., Shroyer, N. F., Matthaei, K. I., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.214965 · Cited by 57
Adverse outcome pathway development from protein alkylation to liver fibrosis
Horvat, T., Landesmann, B., Lostia, A., Vinken, M., Munn, S., & Whelan, M. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1814-8 · Cited by 53
“TH2 cells secrete IL-13, a pro-fibrogenic mediator, which can promote fibrosis either by stimulating TGF-β1 synthesis and activation, or independently of TGF-β1, by controlling the relative expression of IL-13 receptors on myofibroblasts (Chiaramonte et al. 1999; Wynn 2004)).”
BackgroundInteractions Between Tissue Fibroblasts in Lymph Nodes and Hodgkin/Reed-Sternberg Cells
Aldinucci, D., Lorenzon, D., Olivo, K., Rapanà, B., & Gattei, V. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190410001683633 · Cited by 61
“IL-13 stimulates collagen synthesis in vitro [21,22], is a potent stimulator and activator of TGF-b in vivo and is implicated in the”
BackgroundInduction and regulation of pathogenic Th17 cell responses in schistosomiasis
Larkin, B. M., Smith, P. M., Ponichtera, H. E., Shainheit, M. G., Rutitzky, L. I., & Stadecker, M. J. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0341-9 · Cited by 58
“However, during the chronic phase of schistosomiasis, the Th2 cell-derived cytokine IL-13 contributes to hepatic fibrosis [50, 51]; this pathogenic attribute of Th2 cells is covered more extensively in the review article by Fairfax et al.”
BackgroundStromal and immune cells in gut fibrosis: the myofibroblast and the scarface
Valatas, V., Filidou, E., Drygiannakis, I., & Kolios, G. (2017) · Annals of Gastroenterology · doi:10.20524/aog.2017.0146 · Cited by 69
“Stimulation of myofibroblasts with IL-4 results in increased collagen production [99], whereas IL-13 regulates their TGF-β expression levels [100].”
BackgroundChlamydia Spreading from the Genital Tract to the Gastrointestinal Tract – A Two-Hit Hypothesis
Zhong, G. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.12.002 · Cited by 58
Wamachi, A. N., Mayadev, J., Mungai, P., Magak, P., Ouma, J. H., Magambo, J., Muchiri, E. M., Koech, D. K., King, C. H., & King, C. L. (2004) · The Journal of Infectious Diseases · doi:10.1086/425579 · Cited by 63
“IL-13 is produced by CD4 T cells in granulomas that induce fibrosis [32], and its enhanced production may also be associated with an increased risk for bladder-wall disease.”
BackgroundChiaramonte, M. G., Hesse, M., Cheever, A. W., & Wynn, T. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.973 · Cited by 55
“Results were normalized for the relative quantity of total mRNA by comparison to HPRT (39).”
Self-citationBabaloo, Z., Kaye, P. M., & Eslami, M. B. (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90344-x · Cited by 53
Saw, V. P. J., Offiah, I., Dart, R., GALATOWICZ, G. E., Dart, J. K. G., Daniels, J. T., & Calder, V. L. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090579 · Cited by 53
Singh, K. P., Gérard, H. C., Hudson, A. P., & Boros, D. L. (2004) · Immunology · doi:10.1111/j.0019-2805.2004.01817.x · Cited by 54
Arnaud, V., Li, J., Wang, Y., Fu, X., Mengzhi, S., Luo, X., Hou, X., Dessein, H., Jie, Z., Xin‐Ling, Y., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/588826 · Cited by 64
“Th2 cytokines (IL-4 and IL-13) are fibrogenic (3-5), whereas IFN-γ inhibits the production of ECMP and increases collagenase activity by stimulating matrix metalloproteases (MMP) and inhibiting tissue inhibitors of MMP (TIMP) (6-8).”
Innate Lymphoid Cells in Immunity and Disease
Hwang, Y. Y., & McKenzie, A. N. J. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-6217-0_2 · Cited by 60
Piper, M., Mueller, A. C., & Karam, S. D. (2020) · Molecular Carcinogenesis · doi:10.1002/mc.23205 · Cited by 56
“collagen production and an important mediator in the progression of fibrosis in several organ systems.(69,70) Fibrosis in the lung and liver have both been shown to be heavily dependent on IL‐13 activity, and mice deficient of IL‐13 exhibit an antifibrotic phenotype.”
BackgroundAugmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumonia
Jakubzick, C., Choi, E. S., Kunkel, S. L., Evanoff, H. L., Martinez, F. J., Puri, R. K., Flaherty, K. R., Toews, G. B., Colby, T. V., Kazerooni, E. A., et al. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.012799 · Cited by 56
Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD
Jacob, N., Targan, S. R., & Shih, D. Q. (2016) · United European Gastroenterology Journal · doi:10.1177/2050640616649356 · Cited by 53
“Similarly, IL-13 blockade reduces experimental hepatic fibrosis.(67) In TNBS-induced colitis, inhibition of IL-13 signaling by administration of small interfering RNA targeting the IL-13Ra2, reduces fibrosis and expression of TGFb.”
BackgroundPulmonary vascular disease associated with parasitic infection—the role of schistosomiasis
Kołosionek, E., Graham, B. B., Tuder, R. M., & BUTROUS, G. S. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03308.x · Cited by 51
“IL-13 has been reported to be induced after Schistosoma infection [45,51,52,59,69], and several studies performed in mice using IL-13 suppression [81] and inhibition [82], demonstrated decreased inflammation after Schistosoma infection.”
ResultRay, D., Nelson, T. A., Fu, C., Patel, S., Gong, D. N., Odegaard, J. I., & Hsieh, M. H. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001912 · Cited by 53
Immunoinflammatory responses and fibrogenesis
Azouz, A., Razzaque, M. S., El-Hallak, M., & Taguchi, T. (2004) · Medical Molecular Morphology · doi:10.1007/s00795-004-0255-2 · Cited by 50
“The soluble IL-13 receptor (sIL13Rα2-Fc)*fusion protein has shown to successfully block fibrogenic effects of IL-13.(73) IL-13-mediated hepatic fibrosis dramatically increased in the absence of IL-13Rα2, despite the fact that the production of local Th2 cytokine reduced significantly, suggesting an important decoy fun…”
BackgroundInfluentialSchistosome infection and its effect on pulmonary circulation
BUTROUS, G. S. (2019) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2019.5 · Cited by 52
Behind Enemy Lines: Immunomodulatory Armamentarium of the Schistosome Parasite
Angeles, J. M. M., Mercado, V. J. P., & Rivera, P. T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01018 · Cited by 70
“Eosinophil infiltration in the granuloma is mediated by IL-5 and IL-13 (112, 127, 129, 130).”
BackgroundInfluentialSingh, K. P., Gerard, H. C., Hudson, A. P., & Boros, D. L. (2004) · Annals of Tropical Medicine and Parasitology · doi:10.1179/000349804225021316 · Cited by 48
“At the onset of the granulomatous inflammation, collagen-isotype gene expression and collagen deposition are likely to be induced by secreted fibrogenic cytokines such as TGF-b (Czaja et al., 1989a) and IL-13 (Chiaramonte et al., 1999; Fallon et al., 2000).”
BackgroundJakubzick, C., Choi, E. S., Kunkel, S. L., Joshi, B. H., Puri, R. K., & Hogaboam, C. M. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64280-0 · Cited by 52
“mansoni eggs.(26) In the present study, we observed that IL-13R 2 protein was not constitutively expressed on the cell surface of any of the fibroblast cell lines, despite the increased gene expression for this receptor subunit in type 1 compared with untreated normal fibroblasts.”
BackgroundInfluentialFattouh, R., & Jordana, M. (2008) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152808786848388 · Cited by 48
“IL-13 can also activate human airway fibroblasts and can directly trigger collagen production to a similar extent as that induced by TGF- 1, in vitro [117-119].”
BackgroundEvaluation of interleukin 13 polymorphisms in systemic sclerosis
Granel, B., Chevillard, C., Allanore, Y., Arnaud, V., Cabantous, S., Marquet, S., Weiller, P., Durand, J. M., Harlé, J., Grangé, C., et al. (2006) · Immunogenetics · doi:10.1007/s00251-006-0135-0 · Cited by 47
“IL-13 deregulation is thought to play an important role in the pathogenesis of other human diseases, including asthma (Wills-Karp and Chiaramonte 2003), idiopathic pulmonary fibrosis (Hancock et al. 1998), hepatic fibrosis ( Chiaramonte et al. 1999 ), nodular sclerosing Hodgkin’ sd isease (Ohshima et al. 2001), keloid…”
BackgroundInfluentialThe Role of T Lymphocytes in Cutaneous Scarring
Short, W. D., Wang, X., & Keswani, S. G. (2021) · Advances in Wound Care · doi:10.1089/wound.2021.0059 · Cited by 49
“32,34 STAT6 then activates genes promoting collagen synthesis and TGF-b1 expression.34 An exaggerated Th2 response is responsible for fibrosis in hepatic and schistosomal infection models, primarily due to overproduction of IL-13.”
BackgroundPossible involvement of Toll-like receptor 7 in the development of type 1 autoimmune pancreatitis
Fukui, Y., Uchida, K., Sakaguchi, Y., Fukui, T., Nishio, A., Shikata, N., Sakaida, N., Uemura, Y., Satoi, S., & Okazaki, K. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-0977-4 · Cited by 48
“Th2 cytokines are implicated in fibrosis formation in lung and hepatic models of chronic disease [76–78].”
BackgroundTh2-Biased Immune Responses Are Important in a Murine Model of Chronic Hypersensitivity Pneumonitis
Mitaka, K., Miyazaki, Y., Yasui, M., Furuie, M., Miyake, S., Inase, N., & Yoshizawa, Y. (2010) · International Archives of Allergy and Immunology · doi:10.1159/000321114 · Cited by 55
B cells: no longer bystanders in liver fibrosis
Bhogal, R. K. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26845 · Cited by 46
Giraud, J., Chalopin, D., Ramel, E., Boyer, T., Zouine, A., Derieppe, M., Larmonier, N., Adotévi, O., Bail, B. L., Blanc, J., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113773 · Cited by 51
New Insights into the Mechanisms of Innate Immune Receptor Signalling in Fibrosis
Lafyatis, R., & Farina, G. A. (2012) · The Open Rheumatology Journal · doi:10.2174/1874312901206010072 · Cited by 49
“IL-4 and more consistently IL-13 have been implicated in fibrosis in several animal models, including colitis [84], pulmonary fibrosis [85], and schistosomiasis [86].”
BackgroundUpregulation of Interleukin-13 and Its Receptor in a Murine Model of Bleomycin-Induced Scleroderma
Matsushita, M., Yamamoto, T., & Nishioka, K. (2004) · International Archives of Allergy and Immunology · doi:10.1159/000082331 · Cited by 45
Gangadharan, B., Hoeve, M. A., Allen, J. E., Ebrahimi, B., Rhind, S. M., Dutia, B. M., & Nash, A. A. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507270 · Cited by 44
“These processes can be inhibited by regulating the expression of IL-13 using blocking antibodies, soluble receptors, or chimeric proteins [59], demonstrating a crucial role for this cytokine in tissue remodeling.”
BackgroundModulation of pulmonary fibrosis by IL-13Rα2
Lumsden, R. V., Worrell, J. C., Boylan, D., Walsh, S. M., Cramton, J., Counihan, I. P., O’Beirne, S. L., Medina, M. F. C., Gauldie, J., Fabre, A., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00120.2014 · Cited by 44
“When IL-13 and IL-4 were neutralized independently, it emerged that IL-13 was the dominant cytokine in driving the pathogenesis of fibrosis (8, 15, 16).”
BackgroundObligatory Role for Interleukin-13 in Obstructive Lesion Development in Airway Allografts
Lama, V. N., Harada, H., Badri, L. N., Flint, A., Hogaboam, C. M., McKenzie, A. N. J., Martínez, F. J., Toews, G. B., Moore, B. B., & Pinsky, D. J. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050975 · Cited by 44
“22 Neutralization of IL-13 can ameliorate Schistosoma mansoni -induced hepatic fibrosis 23 as well as bleomycin-induced alveolar fibrosis.”
Backgrounddos Santos, H. A. M., Dutra, F. F., Rocha, C. C., Lino, F. G., Xavier, F. R., Chinalia, L. A., Hossy, B. H., Castelo-Branco, M. T. L., Teodoro, A. J., Paiva, C. N., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01936-13 · Cited by 44
“The role of IL-4 in fibrogenesis is controversial (17, 19) and possibly mistaken as fibrogenic due to impaired IL-13 responses in IL-4-deficient mice (18, 19).”
BackgroundMagalhães, E. S. D. S., Paiva, C. N., de Souza, H. S. P., Pyrrho, A. S., Mourão‐Sá, D., Figueiredo, R. T., Vieira‐de‐Abreu, A., Dutra, H. S., Silveira, M. S., Elsas, M., et al. (2008) · The FASEB Journal · doi:10.1096/fj.08-124248 · Cited by 52
“However, the plasma concentrations of IL-5, IL-13, and IgE were independent of MIF, indicating that it is not critical to Th2 polarization.”
BackgroundInfluentialChan, E. S. L., & Cronstein, B. N. (2009) · Modern Rheumatology · doi:10.1007/s10165-009-0251-4 · Cited by 46
Soluble Interleukin-13Rα2 Decoy Receptor Inhibits Hodgkin’s Lymphoma Growthin Vitroandin Vivo
Trieu, Y., Wen, X., Skinnider, B., Bray, M. R., Li, Z.-H., Claudio, J. O., Masih‐Khan, E., Zhu, Y.-X., Trudel, S., McCart, J. A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3764 · Cited by 44
“Interestingly, a soluble IL-13R 2-Fc (sIL-13R 2-Fc) fusion protein has been engineered to specifically block the detrimental effects induced by IL-13, including asthma (11, 12) and Schistosoma mansoni-induced hepatic fibrosis (25).”
BackgroundDifferential Liver Protein Expression during Schistosomiasis
Harvie, M., Jordan, T. W., & Flamme, A. C. L. (2006) · Infection and Immunity · doi:10.1128/iai.01048-06 · Cited by 42
“Another Th2 cytokine, IL-13, mediates the fibrotic process (21), and expression of its decoy receptor, IL-13R2 , has been shown to be essential in the resolution of fibrosis (13).”
BackgroundPark, M. K., Hoffmann, K. F., Cheever, A. W., Amichay, D., Wynn, T. A., & Farber, J. M. (2001) · Infection and Immunity · doi:10.1128/iai.69.11.6755-6768.2001 · Cited by 48
“We have investigated these roles by measuring cytokine expression in lymphoid and peripheral tissues, by blocking or eliminating cytokines by using antibodies or knockout mice, respectively, and by administering cytokine along with sensitizing antigen as part of strategies for immunization (8, 9, 14, 23, 55, 57).”
BackgroundSelf-citationEarly Regulation of Profibrotic Genes in Primary Human Cardiac Myocytes by Trypanosoma cruzi
Udoko, A. N., Johnson, C., Dykan, A., Rachakonda, G., Villalta, F., Mandape, S. N., Lima, M. F., Pratap, S., & Nde, P. N. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003747 · Cited by 41
“Th2 cytokines IL-4, IL-5 and IL-13 are dramatically increased in liver fibrosis with IL-13 being an indispensable mediator of fibrosis [69].”
Background
Metadata
- Authors
- Chiaramonte, M. G., Donaldson, D. D., Cheever, A. W., & Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Biomedical Research Institute (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Wynn, Thomas A.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-09-15
- Volume
- 104
- Issue
- 6
- Pages
- 777-785
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC408441
- OpenAlex
- W1975021657
- Cited by
- 603
- References
- 47
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 7 · 2023: 8 · 2022: 14 · 2021: 16 · 2020: 21 · 2019: 13 · 2018: 34 · 2017: 18 · 2016: 30 · 2015: 28 · 2014: 35 · 2013: 23 · 2012: 30
- FWCI
- 19.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- IL-13, liver fibrosis, schistosomiasis, Schistosoma mansoni, Th2 cytokines, IL-4, granuloma formation, collagen synthesis, fibroblasts, procollagen mRNA, antifibrotic therapy
- MeSH terms
- Animals, Female, Liver, Liver Cirrhosis, Experimental, Mice, Inbred C57BL, Procollagen, RNA, Messenger, Schistosomiasis mansoni, Interleukin-4, Cytokines, 3T3 Cells, Mice, Knockout, Th1 Cells, Th2 Cells, Interleukin-13, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.